135 related articles for article (PubMed ID: 36445335)
21. Exploration of the design principles of a cell-penetrating bicylic peptide scaffold.
Wallbrecher R; Depré L; Verdurmen WP; Bovée-Geurts PH; van Duinkerken RH; Zekveld MJ; Timmerman P; Brock R
Bioconjug Chem; 2014 May; 25(5):955-64. PubMed ID: 24697151
[TBL] [Abstract][Full Text] [Related]
22. Impact of Peptide Sequence on Functional siRNA Delivery and Gene Knockdown with Cyclic Amphipathic Peptide Delivery Agents.
Jagrosse ML; Baliga UK; Jones CW; Russell JJ; García CI; Najar RA; Rahman A; Dean DA; Nilsson BL
Mol Pharm; 2023 Dec; 20(12):6090-6103. PubMed ID: 37963105
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and antiproliferative activities of doxorubicin thiol conjugates and doxorubicin-SS-cyclic peptide.
Darwish S; Sadeghiani N; Fong S; Mozaffari S; Hamidi P; Withana T; Yang S; Tiwari RK; Parang K
Eur J Med Chem; 2019 Jan; 161():594-606. PubMed ID: 30396106
[TBL] [Abstract][Full Text] [Related]
24. [Comparison of mechanisms and cellular uptake of cell-penetrating peptide on different cell lines].
Ma DX; Qi XR
Yao Xue Xue Bao; 2010 Sep; 45(9):1165-9. PubMed ID: 21351574
[TBL] [Abstract][Full Text] [Related]
25. Design and biological evaluation of cell-penetrating peptide-doxorubicin conjugates as prodrugs.
Nasrolahi Shirazi A; Tiwari R; Chhikara BS; Mandal D; Parang K
Mol Pharm; 2013 Feb; 10(2):488-99. PubMed ID: 23301519
[TBL] [Abstract][Full Text] [Related]
26. Redox-Responsive Disulfide Cyclic Peptides: A New Strategy for siRNA Delivery.
Mandal D; Mohammed EHM; Lohan S; Mandipoor P; Baradaran D; Tiwari RK; Parang K; Aliabadi HM
Mol Pharm; 2022 May; 19(5):1338-1355. PubMed ID: 35347995
[TBL] [Abstract][Full Text] [Related]
27. Endocytosis, intracellular traffic and fate of cell penetrating peptide based conjugates and nanoparticles.
Cleal K; He L; Watson PD; Jones AT
Curr Pharm Des; 2013; 19(16):2878-94. PubMed ID: 23140451
[TBL] [Abstract][Full Text] [Related]
28. (18)F-Labeled phosphopeptide-cell-penetrating peptide dimers with enhanced cell uptake properties in human cancer cells.
Richter S; Bouvet V; Wuest M; Bergmann R; Steinbach J; Pietzsch J; Neundorf I; Wuest F
Nucl Med Biol; 2012 Nov; 39(8):1202-12. PubMed ID: 22784382
[TBL] [Abstract][Full Text] [Related]
29. Uptake and intracellular traffic of siRNA dendriplexes in glioblastoma cells and macrophages.
Perez AP; Cosaka ML; Romero EL; Morilla MJ
Int J Nanomedicine; 2011; 6():2715-28. PubMed ID: 22114502
[TBL] [Abstract][Full Text] [Related]
30. Mechanism of ribonuclease A endocytosis: analogies to cell-penetrating peptides.
Chao TY; Raines RT
Biochemistry; 2011 Oct; 50(39):8374-82. PubMed ID: 21827164
[TBL] [Abstract][Full Text] [Related]
31. Kinetic uptake profiles of cell penetrating peptides in lymphocytes and monocytes.
Rodrigues M; de la Torre BG; Andreu D; Santos NC
Biochim Biophys Acta; 2013 Oct; 1830(10):4554-63. PubMed ID: 23707662
[TBL] [Abstract][Full Text] [Related]
32. Characterization of the cell penetrating properties of a human salivary proline-rich peptide.
Radicioni G; Stringaro A; Molinari A; Nocca G; Longhi R; Pirolli D; Scarano E; Iavarone F; Manconi B; Cabras T; Messana I; Castagnola M; Vitali A
Biochim Biophys Acta; 2015 Nov; 1848(11 Pt A):2868-77. PubMed ID: 26325345
[TBL] [Abstract][Full Text] [Related]
33. Effects of cargo molecules on the cellular uptake of arginine-rich cell-penetrating peptides.
Maiolo JR; Ferrer M; Ottinger EA
Biochim Biophys Acta; 2005 Jun; 1712(2):161-72. PubMed ID: 15935328
[TBL] [Abstract][Full Text] [Related]
34. Cyclic Peptide-Gadolinium Nanocomplexes as siRNA Delivery Tools.
Nasrolahi Shirazi A; Sajid MI; Mandal D; Stickley D; Nagasawa S; Long J; Lohan S; Parang K; Tiwari RK
Pharmaceuticals (Basel); 2021 Oct; 14(11):. PubMed ID: 34832846
[TBL] [Abstract][Full Text] [Related]
35. Characterization of the cell-penetrating properties of the Epstein-Barr virus ZEBRA trans-activator.
Rothe R; Liguori L; Villegas-Mendez A; Marques B; Grunwald D; Drouet E; Lenormand JL
J Biol Chem; 2010 Jun; 285(26):20224-33. PubMed ID: 20385549
[TBL] [Abstract][Full Text] [Related]
36. Design and application of hybrid cyclic-linear peptide-doxorubicin conjugates as a strategy to overcome doxorubicin resistance and toxicity.
Mozaffari S; Salehi D; Mahdipoor P; Beuttler R; Tiwari R; Aliabadi HM; Parang K
Eur J Med Chem; 2021 Dec; 226():113836. PubMed ID: 34537446
[TBL] [Abstract][Full Text] [Related]
37. Early endosomal escape of a cyclic cell-penetrating peptide allows effective cytosolic cargo delivery.
Qian Z; LaRochelle JR; Jiang B; Lian W; Hard RL; Selner NG; Luechapanichkul R; Barrios AM; Pei D
Biochemistry; 2014 Jun; 53(24):4034-46. PubMed ID: 24896852
[TBL] [Abstract][Full Text] [Related]
38. Cell-penetrating peptide sequence and modification dependent uptake and subcellular distribution of green florescent protein in different cell lines.
Patel SG; Sayers EJ; He L; Narayan R; Williams TL; Mills EM; Allemann RK; Luk LYP; Jones AT; Tsai YH
Sci Rep; 2019 Apr; 9(1):6298. PubMed ID: 31000738
[TBL] [Abstract][Full Text] [Related]
39. From Pulmonary Surfactant, Synthetic KL4 Peptide as Effective siRNA Delivery Vector for Pulmonary Delivery.
Qiu Y; Chow MYT; Liang W; Chung WWY; Mak JCW; Lam JKW
Mol Pharm; 2017 Dec; 14(12):4606-4617. PubMed ID: 29121767
[TBL] [Abstract][Full Text] [Related]
40. Amphiphilic Peptides for Efficient siRNA Delivery.
Mozaffari S; Bousoik E; Amirrad F; Lamboy R; Coyle M; Hall R; Alasmari A; Mahdipoor P; Parang K; Montazeri Aliabadi H
Polymers (Basel); 2019 Apr; 11(4):. PubMed ID: 30999603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
